Signaling Pathways - DREADD Ligands - O6-methylguanine-DNA-methyl-transferase (MGMT) - Liver X receptors (LXRs) - MK2
清除全部
-
C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂 -
A8714 SR-9243Target: Liver X receptors (LXRs)Summary: LXR反相激动剂 -
B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂 -
B5549 PF-3644022Target: MK2Summary: MK2抑制剂 -
B1264 LXR-6232 CitationTarget: Liver X receptors (LXRs)Summary: 肝X受体激动剂 -
A2249 T0901317Target: Liver X receptors (LXRs)Summary: 肝X受体激动剂 -
A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂 -
A3454 GW39651 CitationTarget: Liver X receptors (LXRs)Summary: 高效选择性HLXRα/hLXRβ激动剂 -
A3317 Clozapine N-oxide(CNO)1 Citation中文名: 氯氮平的N-氧化物Target: DREADD LigandsSummary: Clozapine代谢产物，用于化学遗传学 -
A1912 Lomeguatrib中文名: 罗米鲁曲Target: O6-methylguanine-DNA-methyl-transferase (MGMT)Summary: MGMT抑制剂